發(fā)布時(shí)間：2018-05-06 11:22

  本文選題：乙型肝炎病毒 + X蛋白　； 參考：《南華大學(xué)》2007年碩士論文

【摘要】： 目的:應(yīng)用酵母雙雜交法檢測(cè)乙型肝炎病毒(HBV)X蛋白(HBx)與hDaxx的相互作用,并初步探討其相互作用后對(duì)細(xì)胞凋亡的影響,為進(jìn)一步研究HBx在HBV慢性感染致癌機(jī)制中的作用提供一定的實(shí)驗(yàn)依據(jù)。 方法: (1)構(gòu)建酵母菌真核表達(dá)載體pGADT7-HBx:根據(jù)已知的HBV X基因序列,采用Primer Premier5.0軟件設(shè)計(jì)一對(duì)引物,并分別引入EcoR I與Xho I酶切位點(diǎn),PCR擴(kuò)增X基因;用EcoRI和Xho I分別雙酶切PCR產(chǎn)物和質(zhì)粒pGADT7,分別純化回收酶切產(chǎn)物,T4連接酶連接后,轉(zhuǎn)化大腸桿菌DH5α,篩選陽(yáng)性克隆。對(duì)重組質(zhì)粒進(jìn)行酶切及測(cè)序鑒定。 (2)構(gòu)建酵母菌真核表達(dá)載體pGBKT7-hDaxx:用EcoRI和SalI分別雙酶切質(zhì)粒pGBDU-C1/hDaxx和pGBKT7,分別純化回收酶切產(chǎn)物,T4連接酶連接后,轉(zhuǎn)化大腸桿菌DH5α,篩選到陽(yáng)性克隆后,對(duì)重組質(zhì)粒行酶切鑒定。 (3)酵母雙雜交檢測(cè)HBx與hDaxx的相互作用:將酵母菌真核表達(dá)載體及酵母菌陰性陽(yáng)性對(duì)照質(zhì)粒分4組轉(zhuǎn)化酵母菌AH109,A組為pGADT7和pGBKT7、B組為pGADT7-HBx和pGBKT7-hDaxx、C組為pGADT7-T和pGBKT7-Lam、D組為pGADT7-T和pGBKT7-p53,將轉(zhuǎn)化菌落接種于SD/-Trp-Leu(二缺)固體平板,30℃培養(yǎng)2～4d。將單個(gè)菌落接種于SD/-Trp-Leu-His(三缺)和SD/-Trp-Leu-His-Ade(四缺)平板,30℃培養(yǎng)2～4d。裂解酵母菌,提取蛋白,經(jīng)SDS-PAGE、Western blot檢測(cè)hDaxx和HBx在酵母中的表達(dá)。 (4)流式細(xì)胞術(shù)檢測(cè)細(xì)胞凋亡:將HBV X基因穩(wěn)定轉(zhuǎn)染入HepG2細(xì)胞(即HepG2X),再瞬時(shí)轉(zhuǎn)染15μg、30μg和45μg pcDAN3.1-hDaxx,以pcDNA3.1(+)轉(zhuǎn)染HepG2X組和HepG2X組分別作為對(duì)照。用10mmol/L的5-氟尿嘧啶(5-FU)處理36h后分別收集各組細(xì)胞,經(jīng)75%的乙醇4℃固定過(guò)夜,PI染色后,用流式細(xì)胞儀檢測(cè)各組細(xì)胞的凋亡率。用統(tǒng)計(jì)軟件SPSS13.0對(duì)實(shí)驗(yàn)數(shù)據(jù)進(jìn)行LSD-t檢驗(yàn)分析。 結(jié)果: (1) PCR擴(kuò)增HBV X基因片段(465bp),將X基因克隆至pGADT7載體上,經(jīng)雙酶切及測(cè)序分析,所克隆的目的片段與已知的X基因序列及GeneBank上公布的HBV X基因(Pubmed NC_U95551)序列完全一致。 (2)將pGBDU-C1/hDaxx上的hDaxx基因片段亞克隆至pGBKT7載體上,經(jīng)雙酶切分析,得約2.2kb大小的hDaxx基因片段,與預(yù)期值大小一致。 (3)分4組轉(zhuǎn)化的酵母菌AH109在二缺陷平板上均可長(zhǎng)出白色菌落,但僅有B、D兩組菌可以在三缺和四缺平板上生長(zhǎng),選取B組四缺陷平板上單個(gè)菌落,提取酵母蛋白, Western blot檢測(cè)到hDaxx和HBx在同一株酵母菌株中均有表達(dá)。 (4)將X基因穩(wěn)定轉(zhuǎn)染入HepG2細(xì)胞,Western blot檢測(cè)到HBx在HepG2X細(xì)胞中的表達(dá)。經(jīng)流式細(xì)胞術(shù)檢測(cè),HepG2細(xì)胞用5-FU處理后凋亡率明顯高于未經(jīng)5-FU處理的細(xì)胞組,結(jié)果具有顯著性差異(P0.01);HepG2X組細(xì)胞凋亡率明顯低于空細(xì)胞組,結(jié)果具有顯著性差異(P0.01);而轉(zhuǎn)染pcDAN3.1-hDaxx后,細(xì)胞凋亡率進(jìn)一步降低,但與轉(zhuǎn)染入的pcDAN3.1-hDaxx量沒(méi)有劑量依賴關(guān)系。 結(jié)論: (1)成功地構(gòu)建了pGBKT7-hDaxx和pGADT7-HBx酵母菌真核表達(dá)載體,并可在酵母菌AH109中表達(dá)。 (2) HBx與hDaxx在酵母細(xì)胞內(nèi)存在相互作用。 (3)構(gòu)建了穩(wěn)定表達(dá)HBx的細(xì)胞株HepG2X。 (4) HBx可抑制5-FU誘導(dǎo)的HepG2細(xì)胞凋亡,而hDaxx的高表達(dá)能提高HBx的抑制作用,使細(xì)胞凋亡率進(jìn)一步降低。
[Abstract]:Objective: to detect the interaction between hepatitis B virus (HBV) X protein (HBx) and hDaxx by yeast two hybrid method, and to explore the effect of its interaction on cell apoptosis, so as to provide some experimental evidence for further study of the role of HBx in the pathogenesis of HBV chronic infection.
Method:
(1) to construct the eukaryotic expression vector pGADT7-HBx:, a pair of primers were designed based on the known HBV X gene, and Primer Premier5.0 software was used to design a pair of primers, and EcoR I and Xho I enzyme cut sites were introduced, and X gene was amplified by PCR. Escherichia coli DH5 alpha was screened and positive clones were screened. The recombinant plasmid was identified by restriction enzyme digestion and sequencing.
(2) construction of yeast eukaryotic expression vector pGBKT7-hDaxx: with EcoRI and SalI double enzyme cut plasmids pGBDU-C1/hDaxx and pGBKT7 respectively, purification and recovery of the enzyme cut products, T4 ligase connection, the transformation of Escherichia coli DH5 alpha, after screening the positive clones, the recombinant plasmid was identified by enzyme digestion.
(3) the interaction between HBx and hDaxx was detected by yeast two hybrid: the yeast eukaryotic expression vector and the yeast negative positive control plasmid were divided into 4 groups of yeast AH109, A group pGADT7 and pGBKT7, B group pGADT7-HBx and pGBKT7-hDaxx, C group pGADT7-T and pGBKT7-Lam. In the solid plate, a single colony was inoculated to SD/-Trp-Leu-His (three deficient) and SD/-Trp-Leu-His-Ade (four deficient) plate at 30 C for 2 ~ 4d., and 2 ~ 4d. lysis yeast was cultured at 30 C, and protein was extracted. The expression of hDaxx and HBx in yeast was detected by SDS-PAGE and Western blot.
(4) flow cytometry was used to detect apoptosis: transfection of HBV X gene into HepG2 cells (HepG2X), then transiently transfected 15 mu g, 30 mu g and 45 mu g pcDAN3.1-hDaxx. The cells were treated with pcDNA3.1 (+) transfected HepG2X group and HepG2X group respectively. The cells were collected with 10mmol/L's fluorouracil, respectively, after 75% ethanol at 4 centigrade. At night, after PI staining, the apoptosis rate of each group was detected by flow cytometry. The data were analyzed by LSD-t with statistical software SPSS13.0.
Result:
(1) the HBV X gene fragment (465bp) was amplified by PCR, and the X gene was cloned to the pGADT7 vector. The target fragment was completely identical with the known sequence of X gene and the HBV X gene (Pubmed NC_U95551) published on GeneBank by double enzyme digestion and sequencing.
(2) the hDaxx gene fragment on pGBDU-C1/hDaxx was subcloned to pGBKT7 vector, and the hDaxx gene fragment of about 2.2Kb size was obtained by double enzyme cutting analysis, which was in accordance with the expected value.
(3) the yeast AH109 transformed by 4 groups could grow white colonies on two defective plates, but only B, D two could grow on three and four vacant plates, selected a single colony on the B group four defect plate and extracted the yeast protein, and Western blot detected that hDaxx and HBx were expressed in the same strain of yeast strain.
(4) the X gene was transfected into HepG2 cells steadily and the expression of HBx in HepG2X cells was detected by Western blot. The apoptosis rate of HepG2 cells treated with 5-FU was significantly higher than that of the group without 5-FU (P0.01). The apoptotic rate in HepG2X group was significantly lower than that in the empty cell group, and the result was significant. Difference (P0.01), and after transfection of pcDAN3.1-hDaxx, the rate of apoptosis decreased further, but there was no dose-dependent relationship with the amount of pcDAN3.1-hDaxx transfected.
Conclusion:
(1) successfully constructed pGBKT7-hDaxx and pGADT7-HBx yeast eukaryotic expression vectors, and can be expressed in yeast AH109.
(2) there is interaction between HBx and hDaxx in yeast cells.
(3) the cell line HepG2X., which is stable to express HBx, is constructed.
(4) HBx can inhibit the apoptosis of 5-FU induced HepG2 cells, while the high expression of hDaxx can enhance the inhibitory effect of HBx and further reduce the apoptosis rate.

【學(xué)位授予單位】：南華大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2007
【分類號(hào)】：R373

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 葛長(zhǎng)勇;孫茂盛;;乙型肝炎病毒免疫逃避機(jī)制研究進(jìn)展[J];云南大學(xué)學(xué)報(bào)(自然科學(xué)版);2007年S3期

2 高國(guó)生;翁彭劍;紀(jì)y=斌;李德周;李永燕;李紅山;丁世雄;;靶向HBx小干擾RNA表達(dá)載體構(gòu)建及其功能探討[J];中國(guó)衛(wèi)生檢驗(yàn)雜志;2011年07期

3 段彪;申元英;;乙肝病毒肝源細(xì)胞培養(yǎng)模型的研究進(jìn)展[J];中國(guó)病原生物學(xué)雜志;2011年08期

4 梁聲強(qiáng);杜娟;詹林盛;;乙型肝炎病毒特異性細(xì)胞毒性T淋巴細(xì)胞在病毒清除過(guò)程中的作用[J];生物技術(shù)通訊;2011年04期

5 劉浩;邢益平;賈一瓊;李軍;王世霞;盧山;黃祖瑚;;N-糖基化移位對(duì)乙型肝炎病毒表面抗原中蛋白核酸疫苗的表達(dá)及免疫原性的影響[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2011年13期

6 ;本刊2011年第10期專題:病原菌及耐藥株檢測(cè)[J];軍醫(yī)進(jìn)修學(xué)院學(xué)報(bào);2011年09期

7 ;[J];;年期

8 ;[J];;年期

9 ;[J];;年期

10 ;[J];;年期

相關(guān)會(huì)議論文 前10條

1 沃健兒;侯偉;劉克洲;李敏偉;陳離偉;胡中榮;劉榮華;胡敏君;;不同結(jié)合臂長(zhǎng)10-23 DNAzymes對(duì)乙型肝炎病毒S基因和C基因表達(dá)的抑制作用[A];2005年浙江省感染病、肝病學(xué)術(shù)會(huì)議論文匯編[C];2005年

2 王春花;成軍;王欣欣;吳煜;劉妍;郎振為;;乙型肝炎病毒前-前-S蛋白在大腸桿菌中的表達(dá)和純化研究[A];中華醫(yī)學(xué)會(huì)全國(guó)第九次感染病學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2006年

3 孔祥平;任向榮;;RNA干擾抑制乙型肝炎病毒的研究進(jìn)展[A];2006年慢性乙型肝炎治療進(jìn)展研討會(huì)資料匯編[C];2006年

4 崣孴玲;蔡光明;張新全;李壯;;中藥活性部位JMS的抗病毒作用評(píng)價(jià)[A];海峽兩岸三地藥理學(xué)學(xué)術(shù)報(bào)告會(huì)論文匯編[C];2001年

5 崣孴玲;蔡光明;張新全;李壯;;中藥活性部位JMS的抗病毒作用評(píng)價(jià)[A];海峽兩岸三地藥理學(xué)學(xué)術(shù)報(bào)告會(huì)論文匯編[C];2001年

6 黃力毅;羅光漢;吳繼周;;慢性肝病患者乙型肝炎病毒BCP變異意義的研究[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)感染病學(xué)術(shù)會(huì)議論文匯編[C];2001年

7 雷宇;黎燕;王蜀強(qiáng);陳壓西;周智;任紅;;乙型肝炎病毒S基因四環(huán)素調(diào)控體系的構(gòu)建及其在真核細(xì)胞中的表達(dá)[A];中華醫(yī)學(xué)會(huì)第十二次全國(guó)病毒性肝炎及肝病學(xué)術(shù)會(huì)議論文匯編[C];2005年

8 孟忠吉;李磊;李新宇;張正茂;張振華;田擁軍;王寶菊;張s，

本文編號(hào)：1852118